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Structures of Trihydroxynaphthalene
Reductase-Fungicide Complexes: Implications
for Structure-Based Design and Catalysis
ment of enough turgor pressure for punching holes in
the cells of hosts during the initiation of disease [1, 2].
Biosynthesis of fungal melanin proceeds through a poly-
ketide path in which acetate units are linked to produce
1,3,6,8-tetrahydroxynaphthalene (4HN). This is followed
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‡DuPont Pharmaceuticals Company by two successive reduction and dehydration steps to
produce 2HN (Figure 1) [3, 4]. In vivo the reduction ofExperimental Station
Wilmington, Delaware 19880 4HN is catalyzed by 1,3,8-trihydroxynaphthalene reduc-
tase (3HNR) and 4HN reductase [5]. The reduction of
1,3,8-trihydroxynaphthalene (3HN) is mediated primarily
by 3HNR, so named because knockouts in the gene
encoding the protein result in the accumulation of 3HNSummary
and its oxidized byproducts in Magnaporthe grisea [6],
the fungal agent responsible for blast disease in rice.Background: Trihydroxynaphthalene reductase cata-
lyzes two intermediate steps in the fungal melanin bio- Dehydrations of scytalone and vermelone are efficiently
catalyzed by scytalone dehydratase (SD) [7, 8].synthetic pathway. The enzyme, a typical short-chain
dehydrogenase, is the biochemical target of three com- The enzymes of fungal melanin biosynthesis are fertile
ground for the discovery of chemical agents for control-mercial fungicides. The fungicides bind preferentially to
the NADPH form of the enzyme. ling rice blast. SD is the target of structure-based inhibi-
tor design programs that have produced picomolar in-
hibitors and potent fungicides [9–16]; there is oneResults: Three X-ray structures of the Magnaporthe
grisea enzyme complexed with NADPH and two com- commercial fungicide that targets SD [17]. 3HNR is the
biochemical target of three commercial fungicides (tri-mercial and one experimental fungicide were deter-
mined at 1.7 A˚ (pyroquilon), 2.0 A˚ (2,3-dihydro-4-nitro- cyclazole, phthalide, and pyroquilon) that are applied to
prevent blast disease in rice (Figure 2) [3]. Additionally, it1H-inden-1-one, 1), and 2.1 A˚ (phthalide) resolutions.
The chemically distinct inhibitors occupy similar space is the subject of discovery efforts seeking new inhibitors
with fungicidal properties [18]. The four fungicides ofwithin the enzyme’s active site. The three inhibitors
share hydrogen bonds with the side chain hydroxyls of Figure 2 are competitive inhibitors of 3HNR with respect
to its naphthol substrate [19].Ser-164 and Tyr-178 via a carbonyl oxygen (pyroquilon
and 1) or via a carbonyl oxygen and a ring oxygen A 2.8 A˚ resolution X-ray structure of 3HNR complexed
with NADPH and tricyclazole shows that the adjacent(phthalide). Active site residues occupy similar positions
among the three structures. A buried water molecule nitrogen atoms of the inhibitor are hydrogen bonded to
the hydroxyl groups of Ser-164 and Tyr-178 in the activethat is hydrogen bonded to the NZ nitrogen of Lys-182
in each of the three structures likely serves to stabilize site of the enzyme [20]. The hydroxyl of Tyr-178 is hydro-
gen bonded to the 29 hydroxyl of NADPH, which is hydro-the cationic form of the residue for participation in ca-
talysis. gen bonded to the e nitrogen of Lys-182. Ser-164, Tyr-
178, and Lys-182 compose the catalytic triad, which
along with a protein length of 283 residues, a coenzyme–Conclusions: The pro S hydrogen of NADPH (which
is transferred as a hydride to the enzyme’s naphthol binding pattern of Gly-Xaa-Xaa-Xaa-Gly-Xaa-Gly, and
its three-dimensional structure defines 3HNR as a typi-substrates) is directed toward the carbonyl carbon of the
inhibitors that mimic an intermediate along the reaction cal member of the super family of short-chain dehydro-
genases [21, 22]. Structures of the free enzyme and thecoordinate. Modeling tetrahydroxynaphthalene and tri-
hydroxynaphthalene in the active site shows steric and 3HNR-NADPH binary complex have a disordered loop
(residues 216–235) that covers a portion of the activeelectrostatic repulsion between the extra hydroxyl oxy-
gen of the former substrate and the sulfur atom of Met- site in the presence of tricyclazole [23].
The two other commercial fungicides (phthalide and283 (the C-terminal residue), which accounts, in part,
for the 4-fold greater substrate specificity for trihydroxy- pyroquilon) that target 3HNR function do not have adja-
cent nitrogen atoms that can share hydrogen bondsnaphthalene over tetrahydroxynaphthalene.
as tricyclazole does; instead they have carbonyl and
lactone functionalities that may share hydrogen bondsIntroduction
with the enzyme residues. The newly discovered fungi-
cide 1 (2,3-dihydro-4-nitro-1H-inden-1-one, Figure 2)Fungal melanin, a polymer of 1,8-dihydroxynaphtahlene
(2HN), serves as a barrier that lines penetration organ- has a carbonyl functionality and a nitro group, either of
which could participate in hydrogen bonding interac-elles of certain invasive fungi and facilitates the develop-
tions [18]. Given the uncertainties of the inhibitor interac-
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Figure 1. The Fungal Melanin Biosynthetic Pathway
Figure 2. Fungicides that Target the Function of Trihydroxynaph-3HNR, 1,3,8-trihydroxynaphthalene reductase. 4HNR, 1,3,6,8-tetra-
thalene Reductasehydroxynaphthalene reductase. SD, scytalone dehydratase
tions with 3HNR, we became interested in determining in comparison to the original ternary complex (3HNR-
NADPH–tricyclazole) that was determined at 2.8 A˚ reso-their orientations within the active site and the differ-
ences in the enzyme conformation among the inhibitor lution; all residues are identified in the pyoquilon com-
plex, 9 are not seen in the phthalide and 1 complexes,complexes. Additionally, we sought to determine several
structures of the enzyme at high resolution to aid in our and 12 residues are not seen in the tricyclazole complex.
3HNR is a homotetramer with 222 symmetry [20], andunderstanding of enzyme function and in the design of
inhibitors. In this work, we report the following three this is the form of the protein found in each of the new
structures. 3HNR-NADPH–1 and 3HNR-NAPDH–phtalidenew structures of the enzyme that were determined at
high resolution: 3HNR-NADPH–phthalide, 3HNR-NADPH– complexes crystallized in the same space group (P3121)
as that reported for the tricyclazole complex (Table 1).pyroquilon, and 3HNR-NADPH–1.
The asymmetric unit contains a tightly associated dimer
with a noncrystallographic 2-fold symmetry. A crystallo-Results and Discussion
graphic 2-fold operation can be used to generate the
tetramer. The 3HNR-NADPH–pyroquilon complex crys-Structure Comparisons and Inhibitor Binding
The three three-dimensional structures of 3HNR com- tallized in a different space group (P212121), whose asym-
metric unit contains the tetramer. A comparison of theplexed with NADPH and inhibitors phthalide, pyroquilon,
and 1 (Figure 2) were solved by molecular replacement, original structure (3HNR-NADPH-tricyclazole) with the
three new structures shows that rms differences of Cafor which we used the coordinates from the original
structure of the enzyme complexed with NADPH and atoms are 0.4 A˚ for each of the new structures. The
largest differences occur in the region between residuestricyclazole [20]. Statistics for data collection and refine-
ment are listed in Table 1. The higher resolution struc- 216 and 235, which constitutes an active site flap (Figure
3a) [23]. The differences in this region of the protein aretures (1.7 A˚ resolution for 3HNR-NADPH-pyroquilon;
2.0 A˚ resolution for 3HNR-NADPH–1; 2.1 A˚ resolution for not due to intermolecular contacts in the crystal. The
active site residues and the cofactor occupy similar po-3HNR-NADPH–phthalide) each have data to support the
locations of additional residues in the N-terminal region sitions among the four structures, as seen in an overlay
Table 1. Statistics for Data Collection and Refinement
1 Phthalide Pyroquilon
Resolution (A˚) 2.1 2.0 1.7
Space group P3121 P3121 P212121
a, b, c (A˚) 142.8, 142.8, 72.9 140.5, 140.5, 72.7 65.0, 143.3, 141.3
Observations 209,443 208,682 543,990
Unique reflections 47,473 54,812 141,563
Highest-resolution shell (A˚) 2.14–2.10 2.03–2.0 1.73–1.70
Completeness (%) 94.6 (76.0) 96.5 (76.4) 97.2 (86.9)
Rmerge (%) 9.2 (28.3) 8.1 (35.1) 7.2 (22.7)
Rwork (%) 20.5 19.5 17.6
Rfree (%) 25.7 24.4 21.3
Rms bond lengths (A˚) 0.012 0.013 0.010
Rms bond angles (8) 1.45 1.47 1.42
Molecules in asymmetric unit 2 2 4
Rmsd of Ca atoms of NCS-related molecule(s) (A˚) 0.14 0.12 0.12
Number of non-hydrogen atoms 4,598 4,417 9,749
Number of waters 419 387 1,281
Numbers in parentheses are the statistics for the highest-resolution shell. Rmerge 5 Shkl(SnjI(hkl,n) 2 ,I(hkl).j)/Sall observation I, where n is the number
of observations for each unique reflection. Rwork 5 (ShkljjFobs(hkl)j 2 jFcal(hkl)jj)/ShkljFobs(hkl)j using 90% of the data with 2 s(I) cutoff in the
refinement. Rfree is calculated with the above formula and 10% of the data with 2 s(I) cutoff not used in refinement.
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Figure 3. Structural Features of the Enzyme-
Fungicide Complexes
(a) Overlays (stereoview) of the Ca traces of
the four X-ray structures of 3HNR-NADPH–
inhibitor complexes. Green, tricyclazole com-
plex; yellow, 1 complex; magenta, phthalide
complex; blue, pyroquilon complex. NADPH
is in red.
(b) Overlays of four inhibitors from their orien-
tation in the active site of 3HNR. The positions
of the inhibitors were obtained by aligning
the Ca atoms of 3HNR of the four ternary
complexes. The top and bottom views are
orthogonal to one another.
(c) Definition of the binding site volume in
the 3HNR-NADPH–pyroquilon complex. The
space-filled model of pyroquilon occupies
50% of the binding site bordered by the pro-
tein (netting).
of the nine residues (Ser-164, Ile-165, Tyr-178, Met-215, acid side chains that constitute the active site (Figure
4) as opposed to main chain atoms. The exceptions areTyr-216, Cys-220, Tyr-223, Trp-243, and Met-283) within
the Ca and the N atoms of Gly-210 and the backbonea 4 A˚ radius of the inhibitors. In comparison to the tri-
atoms of Tyr-216.cyclazole complex, the atoms of the nine residues have
Ser-164 and Tyr-178 are positioned to participate inrms differences of 0.6 A˚ for each of the new structures.
hydrogen bonding interactions with the inhibitor hetero-Water molecules (387–1281) are assigned to the new
atoms. The hydrogen bonding interactions with the twohigher-resolution structures where there were none as-
residues differ among the inhibitors (Figure 4). The adja-signed to the original structure. One of the water mole-
cent nitrogen atoms of tricyclazole accept hydrogenscules is buried in the active site and likely has a role in
from the hydroxyl groups of Ser-164 and Tyr-178,catalysis and inhibitor binding (see below).
whereas the two hydrogens are donated to the carbonylIt is known that the binding constants for tricyclazole
oxygens of pyroquilon and 1. The ring oxygen andare dependent on the enzyme form with the affinity pro-
the carbonyl oxygen of phthalide can serve as hydro-gression 3HNR-NADPH . 3HNR-NADP1 . 3HNR. These
gen acceptors. Having two hydrogen acceptors mayenzyme forms have relative affinities for tricyclazole of
strengthen the protein interactions with tricyclazole and1, 0.03, and 0.002, respectively [19]. The inhibitors have
phthalide over those in pyroquilon and 1, which havesimilar binding potencies to 3HNR-NADPH; Ki(tricycla- single hydrogen acceptors. Hydrogen donation by thezole) 5 2.4 nM, Ki(1) 5 25 nM, Ki(phthalide) 5 2.0 nM, hydroxyl of Thr-166 to that of Ser-164 (OG1-to-OG dis-
Ki(pyroquilon) 5 14 nM [18]. The flat, cyclic molecules tances of 3.0–3.1 A˚ in the new structures) and by the 29
occupy similar space in the active site of 3HNR (Figure hydroxyl of NADPH to the hydroxyl of Tyr-178 (O-to-O
3b). The inhibitors are similar in size (volumes). These distances of 2.8 A˚ in the new structures) strengthen
sizes are as follows: 1, 131 A˚3; phthalide, 151 A˚3; pyroqui- the hydrogen-donating ability of Ser-164 and Tyr-178.
lon 145 A˚3; and tricyclazole, 141 A˚3. The volumes of Hydrogen donation from the NZ of Lys-182 to the 29
the active site cavities with the inhibitors removed are hydroxyl of NADPH strengthens the latter’s hydrogen-
similar among the four 3HNR-NADPH–inhibitor struc- donating ability.
tures, as follows: 1, 330 A˚3; phthalide, 370 A˚3; pyroquilon A common feature in the new structures is that the
290 A˚3; and tricyclazole, 340 A˚3. The volumes indicate pro S hydrogen of NADPH (the hydrogen that is trans-
that about half of the active site space is occupied by ferred as a hydride to the naphthol in the reduction
the inhibitors, which leaves some room for chemical reaction) is directed toward the carbonyl carbon of each
elaboration of the inhibitors for optimizing binding po- inhibitor (Figure 4). The inhibitors are not substrates for
tencies. Figure 3c illustrates the unoccupied space 3HNR-catalyzed reductions. Distances from the methyl-
within the binding cavity of the 3HNR complex with pyro- ene carbon of NADPH to the carbonyl carbon of the
inhibitors vary from 3.3 to 3.6 A˚. In this respect thequilon. The inhibitors interact predominantly with amino
Structure
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Figure 4. Interactions of Inhibitors with Ac-
tive Site Residues
(a) 1.
(b) Phthalide.
(c) Pyroquilon.
(d) Tricyclazole.
Hydrogen bonds are indicated by dashed
lines with distances between nonhydrogen
atoms in A˚. Protein and NADPH atoms with
asterisks are 3.2–3.9 A˚ from the non-hydro-
gen atoms of the inhibitors. Inhibitor atoms
with asterisks are 3.2–3.7 A˚ from the non-
hydrogen atoms of the protein and NADPH.
inhibitors mimic the sp2 center of the keto tautomer of as there is a steric and electrostatic repulsion between
the sulfur atom of the C-terminal Met-283 and the C6the naphthol substrate that accepts the hydride. Another
common feature among the inhibitors is their stacking hydroxyl group of 4HN. The model places the oxygen
of the hydroxyl group 0.93 A˚ away from the sulfur atom,with the phenol ring of Tyr-223. The hydroxyl of Tyr-223
is near the carbonyl of the inhibitors and may provide so there must be some movement of the protein to
accommodate 4HN. The necessary movement presum-some electrostatic attraction.
Other binding interactions are provided by electro- ably comes with a price as the Met-283 sulfur atom
occupies similar positions among the four inhibitorstatic and van der Waals dispersion forces that are inhib-
itor specific. Although the inhibitors generally occupy structures. Movement of the side chain of Met-283 ap-
pears to be constrained by the hydrophobic pocket itsimilar space within the active site, very few of their
atoms occupy the same space (Figure 3b). This makes occupies that is bounded by the inhibitors and the side
chains of Trp-243, Tyr-223, and Ile-165. When 4HN isthe interactions with protein atoms inhibitor dependent
(Figure 4). The chlorines of phthalide and the nitro group placed into the structures, the distances between the
sulfur atom of Met-283 and the C6 hydroxyl oxygen ofof 1 are bounded in the enzyme by CH or CH2 groups
of amino acids. The remainder of the interactions are 4HN are 0.93, 1.3, 1.2, and 1.2 A˚ for the pyroquilon,
1, phthalide, and tricyclazole complexes, respectively.between CH and CH2 groups of the inhibitors and the
protein. This is another indication that there is a measure of
conformational stability for the residue side chain
among the ternary complexes. To accommodate bothSubstrate Specificity
3HN and 4HN, the Met-283 side chain can be envisionedThe 3HNR complexes with the carbonyl-functionalized
moving outward into the solvent. Such a movementinhibitors provide an obvious means of positioning the
would afford an energy penalty due to the entropy asso-naphthol substrates (3HN and 4HN) within the active
ciated with solvation of the greater surface area associ-site. Figure 5a shows the alignment of 4HN with pyroqui-
ated with the hydrophobic side chain. Clearly, the addi-lon. The atoms of pyroquilon map those of the naphthol
tional hydroxyl group of 4HN relative to 3HN engendersquite well. Among the inhibitors studied, the pyroquilon
a greater displacement of the Met-283 into solvent andcomplex offers the closest analogy to the keto tautomer
a greater entropic penalty. Additionally, the C6 hydrogenof substrate in that the inhibitor carbonyl oxygen of the
of 3HN offers an attraction for the sulfur atom of Met-six-membered ring is poised to receive hydrogen atoms
283 instead of the electrostatic repulsion offered by thefrom both Ser-164 and Tyr-178. Figure 5b shows 4HN
C6 hydroxyl of 4HN. In support of this scenario account-in place of pyroquilon in the 3HNR active site. The model
ing for the substrate specificity of 3HNR, the C terminusaccounts for hydride delivery from NADPH to the 4HN si-
of the newly discovered 4HN reductase is one residueface forming the R-configuration product. Additionally,
shorter than that of 3HNR; there is no methionine residuethis model accounts, in part, for 3HNR being 4-fold more
to interfere with 4HN binding, and the enzyme is 300-foldspecific for 3HN over 4HN (kcat/Km comparisons were
determined from substrate competition experiments) [5] more specific for 4HN than for 3HN (kcat/Km comparisons
Trihydroxynaphthalene Reductase-Fungicide Complexes
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Figure 5. Docking of Substrates into the Enzyme Active Site
(a) Modeling of substrate tetrahydroxynaphthalene (4HN) onto the inhibitor pyroquilon.
(b) Replacement of pyroquilon with tetrahydroxynaphthalene in the active site of 3HNR (stereoview). Van der Waals dot surfaces are indicated
for the sulfur atom of Met-283 and the C6 oxygen of 4HN.
(c) Replacement of pyroquilon with vermelone in the active site of 3HNR (stereoview).
were determined from substrate competition experi- An Active Site Water Molecule
In all of the new 3HNR structures there is one waterments) [5]. Involvement of a C-terminal residue in defin-
ing reaction centers has been found in other enzymes molecule buried in the active site (Figure 6). It is hydro-
gen bonded to the NZ atom of Lys-182, the OD1 of Asn-[24–26].
The binding of product vermelone to 3HNR is modeled 138, the NE2 of Gln-142, and the backbone oxygen of
Ser-115. It is likely that the water molecule serves toin Figure 5c. The lowest energy conformation of vermel-
one has an envelope shape for the saturated ring with stabilize the cationic form of Lys-182 for its participation
in the catalytic cycle (see below). Additionally, the waterthe 3-position carbon forming the envelope flap and the
C3 hydroxyl in an equatorial orientation. This conforma- molecule could stabilize the binding of the inhibitors
examined in this work by contributing to the hydrogention is supported by quantum mechanical calculations
and verified by NMR analysis for the analogous scyta- bonding network that proceeds from the water mole-
cule ! NZ of Lys-182 ! 29 OH of NADPH ! OH of Tyr-lone molecule [27]. The hydrogen atom of vermelone
that was derived from NADPH occupies an axial orienta- 178 ! the carbonyl oxygen of the inhibitors. An analogous
active site water molecule hydrogen bonded to a lysinetion as would be dictated by stereoelectronic considera-
tions for the hydride transfer. Thus, the solution confor- of the catalytic triad has been recognized in another of
the short-chain dehydrogenases/reductases (SDR). Inmation of product vermelone is poised for the back
reaction (reduction of NADP1). their paper on the structure of Drosophila lebanonensis
Structure
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Figure 6. Stereoview of the Interactions of
the Active Site Water Molecule in the 3HNR-
NADPH–Pyroquilon Complex
alcohol dehydrogenase, Benach et al. proposed that the S164A, Y178F, and K182L; kcat for Y223F is 0.15% that
of wild-type 3HNR; D. J. et al., unpublished results).active site water serves to stabilize the cationic form of
the catalytic lysine residue [28], as we do here for the
case of 3HNR. An analogous active site water molecule Biological Implications
is also seen in other SDR structures. Examples of such
SDR structures follow, with PDB ID codes given in pa- Rice blast is a perennial disease that has significant
rentheses: the two tropinone reductases (1AE1, 2AE1, detrimental effects on grain production and economies
2AE2) [29], 3a-hydroxysteroid/dihydrodiol dehydroge- worldwide [38]. The three commercial fungicides that
nase (1BDB) [30], GDP-fucose synthetase (1BSV) [31], target the function of 3HNR are important agents for
carbonyl reductase (1CYD) [32], GDP-mannose 4,6 de- controlling the disease. Our finding that the carbonyl
hydratase (1DB3) [33], and enoyl (acyl carrier protein) functionalities of the inhibitors mimic an sp2 center in the
reductase (1QG6) [34]. In some of these SDR structures reaction coordinate of the enzyme-catalyzed reaction
the positive charge of the catalytic lysine is relayed suggests that the inhibitors should not be subject to the
through the 29 OH of NADPH to the catalytic tyrosine development of resistance at the enzyme level, at least
as with 3HNR. with respect to the interactions including Ser-164, Tyr-
178, Lys-182, and Tyr-223, as there would be no selec-
tion pressure for an inactive enzyme. Indeed, from moreThe Catalytic Cycle
The transition state for the enzyme-catalyzed reduction than two decades of field applications of the commercial
fungicides, there is no indication of resistance to theof 3HN to vermelone would be expected to proceed from
the 3-keto form of 3HN (Figure 7). In aqueous solution the 3HNR inhibitors. From the point of view of designing new
inhibitors and fungicides, the challenge is to improveketo tautomers populate a small percentage of the 3HN
tautomers [35], so the active site must assist in the enzyme potency and compound bioavailabilty and
thereby lower the application rate necessary to controlstabilization of the 3-keto form. In our model the C3
carbonyl oxygen of the 3-keto tautomer of 3HN is well disease. Though tricyclazole, phthalide, and pyroquilon
have achieved commercial success, their 1–2 kg/hect-positioned to form hydrogen bonds with Ser-164 and
Tyr-178, with Tyr-178 serving as the ultimate proton are use rates are relatively high and cause millions of
kg of the compounds to be applied worldwide annually.donor and being fed by the hydrogen bond network that
includes the 29 OH of NADPH, the NZ of Lys-182, and The newly commercialized SD inhibitor (carpropamid)
that exhibits a picomolar binding constant is applied atthe water molecule. An analogous proton relay that in-
volves the 29 OH of NAD1 (as well as the 39 OH of NAD1) considerably lower use rates. Unlike the SD inhibitor
binding site, which is large (1000–1200 A˚3) and lipophyllicis implicated in the catalytic cycle of horse liver alcohol
dehydrogenase [36, 37]. During the hydride delivery from and allows for stepwise increases in binding potencies
through additions of appropriate substituents to inhibi-NADPH, the rehybridization at C3 from sp2 to sp3 would
position the product hydroxyl in hydrogen bonding dis- tors [9–16], the 3HNR inhibitor binding site is relatively
small (290–370 A˚3) and less hydrophobic (this work), andtance to the hydroxyl of Tyr-223 if the enol tautomer at
C1 and C2 is maintained. Hence, the latter 3HNR residue it is therefore unamenable to great increases in inhibitor
binding potencies by employing a similar strategy.may also play a role in stabilizing the transition state for
the reduction. In support of this scenario, studies on the Clearly, the availability of multiple three-dimensional
structures of 3HNR complexed with active site inhibitors3HNR site-directed mutants S164A, Y178F, K182L, and
Y223F indicate that they are all severely debilitated in combined with the knowledge that the active site resi-
dues are rather stable among the ternary complexescatalysis (there is no measurable catalytic activity for
Trihydroxynaphthalene Reductase-Fungicide Complexes
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Figure 7. Proposed Mechanism for the
3HNR-Catalyzed Reduction of 3HN to Ver-
melone
R is the remaining portion of NADPH or
NADP1, 29-phospho-ADP.
placement was performed with the program AMoRe [41]. The re-places constraints on the design of new classes of inhib-
ported structure of 3HNR-NADPH–tricyclazole (1YBV) was theitors, and this constitutes a significant advantage to the
searching model, but both NADPH and the inhibitor were removed.chemist. We plan to present a study of the design and
After one round of the crystallographic refinement, a difference Fou-
synthesis of many 3HNR inhibitors soon. rier map was calculated with the program X-PLOR [42, 43], and the
It is remarkable that the four potent and chemically inhibitor model and NADPH molecules were fitted into the electron
density with the program O [44]. Clear electron density was seendistinct inhibitors of 3HNR (Figure 2) were selected from
for NADPH and the inhibitors pyroquilon and 1 in all molecules ofin vivo screens yet have similar localities within the en-
the asymmetric units. Clear electron density for phthalide was seenzyme active site. The antibacterial agent triclosan that
in only one of the two molecules, presumably due to its low solubility.targets the short-chain dehydrogenase enoyl (acyl carrier
Refinement of the structures was through X-PLOR. NCS was used
protein) reductase was also discovered through whole- to restrain the main chain atoms (CA, C, N) in the refinement. Data
organism screening [34]. The NAD1 form of the latter with resolution lower than 8 A˚ were not included in the refinement.
No bulk solvent correction was applied.binds triclosan more strongly than the NADH or free
enzyme forms, and Ward et al. concluded that this is
Generation of Active Site Volumesan advantage for the inhibitor’s performance in vivo be-
We used Cerius2 from MSI, Inc. to remove water molecules andcause the NAD1 form of the enzyme is highly populated
inhibitors from the model generated from the respective PDB files.
due to the 40-fold greater concentration of NAD1 over Valences of both the protein and NADPH cofactor were satisfied with
NADH in cells [34]. Although 3HNR has the opposite hydrogen atoms. The Site Search of the Structure-Based Design
module was used to generate clusters of dummy atoms for inhibitordisposition with tricyclazole, pyroquilon, phthalide, and
binding pockets (one for each monomer unit). The clusters were1 binding with the affinity progression 3HNR-NADPH.
saved as PDB files that were exported to SYBYL (Tripos, Inc). Atoms3HNR-NADP1.3HNR [19], the inhibitors of 3HNR also
in the cluster not associated with the inhibitor binding pocket wereselect a highly populated form of the enzyme as the
removed. The radii of the remaining atoms were set at 0.5 A˚, and
concentration of NADPH exceeds that of NADP1 in cells. the molecular volumes of the clusters were determined with the
MVolume algorithm in SYBYL (Tripos, Inc) [45]. A standard volume
Experimental Procedures contour surface was also generated from the overlap of the cluster
of atoms with the protein (without water molecules and inhibitor and
Protein Crystallization with valences fully satisfied with hydrogen atoms) via the MVolume
Homogeneous 3HNR (cloned from M. grisea) was purified as de- algorithm. The overlap volumes, generally around 10 A˚3, were sub-
scribed [39]. Crystals of the 3HNR-NADPH–1 and 3HNR-NADPH– tracted from the molecular volumes determined for the clusters of
pyroquilon complexes were obtained by cocrystallization of 20–23 atoms.
mg/ml 3HNR (protein in 50 mM Tris-HCl [pH 7.0]) in the presence
of 10 mM NADPH and 2 mM corresponding inhibitor. These two Docking of Vermelone
inhibitors were soluble when they were sonicated in 50 mM Tris- The semiempirical MOPAC program with AM1 parameterization was
HCl (pH 7.0) solutions. The inhibitor phthalide is less soluble in water, used to carry out a full geometry optimization of the envelope confor-
so 10 mM NADPH and 1.0 mM phthalide were added to the protein mation of vermelone having the hydroxyl in the 3-position [27]. We
solution. Centrifugation of the solution prior to the crystallization employed the SYBYL modeling package to align vermelone into
step allowed removal of the precipitated phthalide. All three ternary the 3HNR active site by using the pyroquilon-complexed crystal
complexes were crystallized at 48C by a hanging-drop vapor diffu- structure. The aromatic and aliphatic rings of vermelone were
sion method. The reservoir contained 0.5 ml of the following crystalli- mapped onto the aromatic and 6-membered lactam rings of pyroqui-
zation solutions: 20% PEG 6K, 10% glycerol, and 0.1 M MES-NaOH lon, respectively, which allowed the vermelone 3-position hydroxyl
(pH 5.5) for the 1 complex; 15% PEG 6K, 14% glycerol, and 0.1 M to be mapped onto the pyroquilon carbonyl and the 3-position C-H
HEPES-NaOH (pH 7.0) for the pyroquilon complex; and 14% PEG bond to be directed toward the 4-position carbon of the nicotin-
6K, 14% glycerol, and 0.1M HEPES (pH 7.0) for the phthalide com- amide ring of the cofactor.
plex. The hanging-drop solution contained 2 ml of the protein-
NADPH-inhibitor solution and 2 ml of the solution from the reservoir. Acknowledgment
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The atomic coordinates for the 3HNR complexes have been depos-
ited in the Protein Data Bank with accession codes 1GON (phthal-
ide), 1GO0 (pyroquilon), and 1DOH (compound 1).
